Heron Therapeutics, Inc. (HRTX) stock
HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.00 (-0.74%)
Close on Nov 17, 2026Market cap $53.58MP/E –Yield –
Heron Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Heron Therapeutics's enterprise value was $23.64M on Nov 11, 2026, against $140.09M a year earlier. Over the last 5 years it ranged from $8.58M to $1.39B, with a median of $199.88M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $23.64M | -85.6% |
| 2025 | Dec 31, 2025 | $163.69M | +1.3% |
| 2024 | Dec 31, 2024 | $161.52M | +18.4% |
| 2023 | Dec 29, 2023 | $136.41M | -55.0% |
| 2022 | Apr 29, 2022 | $303.46M | -54.8% |
| 2021 | Dec 31, 2021 | $671.02M | -59.4% |
| 2020 | Dec 31, 2020 | $1.65B | +3.3% |
| 2019 | Dec 31, 2019 | $1.60B | +14.3% |
| 2018 | Dec 31, 2018 | $1.40B | +70.5% |
| 2017 | Dec 29, 2017 | $820.99M | +106.7% |
| 2016 | Dec 30, 2016 | $397.25M | -41.9% |
| 2015 | Dec 31, 2015 | $684.32M | +343.0% |
| 2014 | Dec 31, 2014 | $154.46M | +34.6% |
| 2013 | Dec 31, 2013 | $114.76M | +73.8% |
| 2012 | Apr 30, 2012 | $66.05M | +435.1% |
| 2011 | Jul 29, 2011 | $12.34M | – |
See a number that looks wrong?